[1] LEI S,ZHENG R,ZHANG S,et al.Global patterns of breast cancer incidence and mortality:a population-based cancer registry data analysis from 2000 to 2020［J］.Cancer Commun(Lond),2021,41(11):1183-1194.
[2] LUO C,LI N,LU B,et al.Global and regional trends in incidence and mortality of female breast cancer and associated factors at national level in 2000 to 2019［J］.Chin Med J(Engl),2021,135(1):42-51.
[3] DUGGAN C,TRAPANI D,ILBAWI AM,et al.National health system characteristics,breast cancer stage at diagnosis,and breast cancer mortality:a population-based analysis［J］.Lancet Oncol,2021,22(11):1632-1642.
[4] SHI L,SHENG J,WANG M,et al.Combination therapy of TGF-β blockade and commensal-derived probiotics provides enhanced antitumor immune response and tumor suppression［J］.Theranostics,2019,9(14):4115-4129.
[5] CHIBA A,BAWANEH A,VELAZQUEZ C,et al.Neoadjuvant chemotherapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis［J］.Mol Cancer Res,2020,18(1):130-139.
[6] PARIDA S,WU S,SIDDHARTH S,et al.A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and beta-catenin axes［J］.Cancer Discov,2021,11(5):1138-1157.
[7] PARHI L,ALON-MAIMON T,SOL A,et al.Breast cancer colonization by fusobacterium nucleatum accelerates tumor growth and metastatic progression［J］.Nat Commun,2020,11(1):3259.
[8] MARWAHA AK,MORRIS JA,RIGBY RJ.Hypothesis:bacterial induced inflammation disrupts the orderly progression of the stem cell hierarchy and has a role in the pathogenesis of breast cancer［J］.Med Hypotheses,2020,136:109530.
[9] NEJMAN D,LIVYATAN I,FUKS G,et al.The human tumor microbiome is composed of tumor type-specific intracellular bacteria［J］.Science,2020,368(6494):973-980.
[10] ZUBIRIA-BARRERA C,STOCK M,NEUBERT R,et al.A simple sequence-based filtering method for the removal of contaminants in low-biomass 16S rRNA amplicon sequencing approaches［J］.J Microbiol Methods,2020,178:106060.
[11] EISENHOFER R,MINICH JJ,MAROTZ C,et al.Contamination in low microbial biomass microbiome studies:issues and recommendations［J］.Trends Microbiol,2019,27(2):105-117.
[12] MOOSSAVI S,SEPEHRI S,ROBERTSON B,et al.Composition and variation of the human milk microbiota are influenced by maternal and early-life factors［J］.Cell Host Microbe,2019,25(2):324-335.
[13] DONNET-HUGHES A,PEREZ PF,DORE J,et al.Potential role of the intestinal microbiota of the mother in neonatal immune education［J］.Proc Nutr Soc,2010,69(3):407-415.
[14] HIEKEN TJ,CHEN J,HOSKIN TL,et al.The microbiome of aseptically collected human breast tissue in benign and malignant disease［J］.Sci Rep,2016,6:30751.
[15] BANERJEE S,TIAN T,WEI Z,et al.Distinct microbial signatures associated with different breast cancer types［J］.Front Microbiol,2018,9:951.
[16]］ MENG S,CHEN B,YANG J,et al.Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy［J］.Front Oncol,2018,8:318.
[17] THOMPSON KJ,INGLE JN,TANG X,et al.A comprehensive analysis of breast cancer microbiota and host gene expression［J］.PLoS One,2017,12(11):e0188873.
[18] XUAN C,SHAMONKI JM,CHUNG A,et al.Microbial dysbiosis is associated with human breast cancer［J］.PLoS One,2014,9(1):e83744.
[19] BANERJEE S,WEI Z,TAN F,et al.Distinct microbiological signatures associated with triple negative breast cancer［J］.Sci Rep,2015,5:15162.
[20] PASCUAL J,MACIAN MC,ARAHAL DR,et al.Multilocus sequence analysis of the central clade of the genus vibrio by using the 16S rRNA,recA,pyrH,rpoD,gyrB,rctB and toxR genes［J］.Int J Syst Evol Microbiol,2010,60(1):154-165.
[21] CHAKRAVORTY S,HELB D,BURDAY M,et al.A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria［J］.J Microbiol Methods,2007,69(2):330-339.
[22] WIDDER S,ALLEN RJ,PFEIFFER T,et al.Challenges in microbial ecology:building predictive understanding of community function and dynamics［J］.Isme J,2016,10(11):2557-2568.
[23] KNIGHT R,VRBANAC A,TAYLOR BC,et al.Best practices for analysing microbiomes［J］.Nat Rev Microbiol,2018,16(7):410-422.
[24] URBANIAK C,CUMMINS J,BRACKSTONE M,et al.Microbiota of human breast tissue［J］.Appl Environ Microbiol,2014,80(10):3007-3014.
[25] WANG H,ALTEMUS J,NIAZI F,et al.Breast tissue,oral and urinary microbiomes in breast cancer［J］.Oncotarget,2017,8(50):88122-88138.
[26] COSTANTINI L,MAGNO S,ALBANESE D,et al.Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S rRNA gene regions［J］.Sci Rep,2018,8(1):16893.
[27] BALDWIN DA,FELDMAN M,ALWINE JC,et al.Metagenomic assay for identification of microbial pathogens in tumor tissues［J］.mBio,2014,5(5):e01714.
[28] JIAN C,LUUKKONEN P,YKI-JARVINEN H,et al.Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling［J］.PLoS One,2020,15(1):e0227285.
[29] BACCHETTI DE GREGORIS T,ALDRED N,CLARE AS,et al.Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa［J］.J Microbiol Methods,2011,86(3):351-356.
[30] RINTTILA T,KASSINEN A,MALINEN E,et al.Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR［J］.J Appl Microbiol,2004,97(6):1166-1177.
[31] VANHOUTTE T,DE PRETER V,DE BRANDT E,et al.Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and saccharomyces boulardii［J］.Appl Environ Microbiol,2006,72(9):5990-5997.
[32] MATSUKI T,WATANABE K,FUJIMOTO J,et al.Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria［J］.Appl Environ Microbiol,2004,70(1):167-173.
[33] LUU TH,MICHEL C,BARD JM,et al.Intestinal proportion of blautia sp is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer［J］.Nutrition and Cancer-an International Journal,2017,69(2):267-275.
[34] WANG RF,CAO WW,CERNIGLIA CE.PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples［J］.Appl Environ Microbiol,1996,62(4):1242-1247.
[35] GUO X,XIA X,TANG R,et al.Development of a real-time PCR method for firmicutes and bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs［J］.Lett Appl Microbiol,2008,47(5):367-373.
[36] PENDERS J,VINK C,DRIESSEN C,et al.Quantification of bifidobacterium spp.,escherichia coli and clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR［J］.FEMS Microbiol Lett,2005,243(1):141-147.
[37] YAMAMURA K,BABA Y,NAKAGAWA S,et al.Human microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis［J］.Clinical Cancer Research,2016,22(22):5574-5581.
[38] ROHDE A,HAMMERL JA,APPEL B,et al.Differential detection of pathogenic Yersinia spp.by fluorescence in situ hybridization［J］.Food Microbiol,2017,62:39-45.
[39] AMANN RI,LUDWIG W,SCHLEIFER KH.Phylogenetic identification and in situ detection of individual microbial cells without cultivation［J］.Microbiol Rev,1995,59(1):143-169.
[40] STEPINSKA M,OLSZEWSKA-SOSINSKA O,LAU-DWORAK M,et al.Identification of intracellular bacteria in adenoid and tonsil tissue specimens:the efficiency of culture versus fluorescent in situ hybridization(FISH)［J］.Curr Microbiol,2014,68(1):21-29.
[41] BALHOUSE BN,PATTERSON L,SCHMELZ EM,et al.N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment:implications for breast cancer viability and proliferation in vitro［J］.PLoS One,2017,12(7):e0180372.
[42] CHEN P,SUN W,HE Y.Comparison of the next-generation sequencing(NGS) technology with culture methods in the diagnosis of bacterial and fungal infections［J］.J Thorac Dis,2020,12(9):4924-4929.
[43] SAUD HUSSEIN A,IBRAHEEM SALIH N,HASHIM SAADOON I.Effect of microbiota in the development of breast cancer［J］.Arch Razi Inst,2021,76(4):761-768.
[44] THYAGARAJAN S,ZHANG Y,THAPA S,et al.Comparative analysis of racial differences in breast tumor microbiome［J］.Sci Rep,2020,10(1):14116.
[45] JARMAN R,RIBEIRO-MILOGRANA S,KALLE W.Potential of the microbiome as a biomarker for early diagnosis and prognosis of breast cancer［J］.J Breast Cancer,2020,23(6):579-587.
[46] DIELEMAN S,AARNOUTSE R,ZIEMONS J,et al.Exploring the potential of breast microbiota as biomarker for breast cancer and therapeutic response［J］.Am J Pathol,2021,191(6):968-982.
[47] TZENG A,SANGWAN N,JIA M,et al.Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer［J］.Genome Med,2021,13(1):60.
[48] NORUM JH,ANDERSEN K,SORLIE T.Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy［J］.Br J Surg,2014,101(8):925-938.
[49] BARZGAR BAROUGH N,SAJJADIAN F,JALILZADEH N,et al.Understanding breast cancer heterogeneity through non-genetic heterogeneity［J］.Breast Cancer,2021,28(4):777-791.
[50] MAO AW,BARCK H,YOUNG J,et al.Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients［J］.Clin Transl Oncol,2022,24(3):597-604.